DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 06 · Volume 225 · November 2013 DOI: 10.1055/s-003-25883


22th Annual Meeting of the Working Group “Experimental Neuro-Oncology”
Johannes Wesling Klinikum Minden, Germany, 26th– 27th, April 2013

Chair: Prof. Dr. Bernhard Erdlenbruch
Abstracts (HTML) List of Authors
Editorial
Erdlenbruch, B: Editorial
A1
Schubert, J; Mullins, C; van Gool, S; Vandenberk, L; Linnebacher, M; Classen, CF: In-vitro and in-vivo effects of Cilengitide in Glioblastoma models
A2
Milde, T; Kool, M; Zucknick, M; Korshunov, A; Witt, H; Jugold, M; Deimling, A von; Kulozik, AE; Benner, A; Pfister, S; Witt, O: The Pediatric Brain Tumor Preclinical Testing Program: update and perspectives
A3
Stark, S; Sturm, D; Johann, PD; Gronych, J; Schüller, U; Wechsler-Reya, RJ; Chesler, L; Roussel, MF; Zhu, Y; Witt, O; Hoffmann, GF; Lichter, P; Pfister, S: Molecular Characterization of Medulloblastoma Mouse Models -On the Avenue to More Elaborate Preclinical Testing Strategies
A4
Aasland, D; Reich, T; Christmann, M; Kaina, B: Is MGMT inducible in malignant glioma cells?
A5
Koks, C; De Vleeschouwer, S; Graf, N; Van Gool, S: Oncolytic viruses induce tumor cell death and antitumor immune memory in the GL261 orthotopic mouse glioma model
A6
Josupeit, R; Leuchs, B; Witt, O; Rommelaere, J; Lacroix, J: Cell culture models of pediatric high-grade glioma are susceptible to Parvovirus H-1 induced cytotoxicity
A7
Ecker, J; Oehme, I; Schomburg, A; Mazitschek, R; Korshunov, A; Kool, M; Lodrini, M; Deubzer, HE; Deimling, A von; Kulozik, AE; Pfister, S; Witt, O; Milde, T: Targeting differentially expressed histone deacetylases in Medulloblastoma – novel approach for treatment of high risk patients
A8
Van Gool, S; Pauwels, F; De Vleeschouwer, S: Validation of the HGG-IMMUNO-RPA model in a new cohort of patients with relapsed HGG treated by adjuvant postoperative DC vaccination
A9
Johann, PD; Sturm, D; Milde, T; Bender, S; Stark, S; Seker-Cin, H; Truffaux, N; Grill, J; Witt, O; Kulozik, AE; Lichter, P; Lewis, J; Pfister, S: Targeting H3.3 mutated pediatric high grade gliomas – A high throughput screening approach to identify novel therapeutic agents
A10
Tchoghandjian, A; Jennewein, C; Eckhardt, I; Rajalingam, K; Fulda, S: Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma
A11
Glasow, A; Kaatzsch, P; Eisenbruch, K; Patties, I; Merz, F; Kortmann, RD; Müller, K: Effect of ionizing irradiation on hippocampal cytokine release and neurogenesis in a murine (transgenic) tissue slice model
A12
Deiss, A; Korshunov, A; Witt, H; van Tilburg, C; Deimling, A von; Kulozik, AE; Pfister, S; Witt, O; Milde, T: Personalized pediatric oncology: Targeted Therapy and clinical feasibility
A13
Knizhnik, AV; Roos, WP; Nikolova, T; Kaina, B: Temozolomide induced autophagy stimulates senescence and inhibits apoptosis in glioma cells